Abstract:Objective 　To identify a novel mutation rtN236V in the hepatitis B virus (HBV) reverse-transcriptase (RT) region of an adefovir dipivoxil (ADV)-refractory patient with chronic hepatitis B, and analyze its phenotypic resistant characteristics. Methods 　HBV DNA was extracted from an ADV-refractory patient with chronic hepatitis B, and the full-length RT region was amplified by nested PCR. The PCR product was cloned into the pGEM-Teasy vector, and then transfected into JM109 cells. Thirty-four clones were randomly selected for DNA sequencing, and drug-resistance-associated mutations were analyzed. After restriction double enzyme digestion and ligation procedure, the 1.1-ploid genome length HBV recombinant plasmids harboring wild type and three different mutants in RT region were constructed. The replication-competent constructs were then transiently transfected into the HepG2 cells. Four hours post-transfection, new medium containing different concentrations of lamivudine, ADV, entecavir and tenofovir were supplemented every other day for 4 days. The phenotypic characteristics of the HBV mutants were analyzed under the drug pressure, the supernatant was collected and HBV DNA production was quantitatively detected using real-time PCR. Results 　Virological and biochemical breakthrough appeared in this patient after ADV treatment for 15 months. Sequence analysis of 34 clones showed that there were 20 strains (58.8%) for rtN236V mutant, 11 (32.4%) for rtN236T, 2 (5.9%) for wild type and 1 (2.9%) for rtA181V+N236V. The relative viral replication capacity of rtN236T, rtN236V and rtA181V+N236V mutants was 89.43%, 83.60% and 75.44% of the wild-type strain, respectively. Phenotypic resistance analysis showed that the susceptibility of mutant harboring rtN236T, rtN236V and rtA181V+N236V was 1/4.75, 1/3.10 and 1/5.10 of the wild-type virus. The three mutants were still susceptible to lamivudine, entecavir and tenofovir. Conclusion 　A novel mutation rtN236V concomitant with rtN236T and rtA181V mutations has been first identified in viral pool of an ADV-refractory patient. rtN236V may decrease the viral replication capacity and the susceptibility to ADV, which might be a novel ADV resistant mutation.

A Putative New Domain Target for Anti‐hepatitis B Virus: Residues Flanking Hepatitis B Virus Reverse Transcriptase Residue 306 (Rtp306)

Substitution Of Proline 306 In The Reverse Transcriptase Domain Of Hepatitis B Virus Regulates Replication

The Amino Acid Substitutions Rtp177g and Rtf249a in the Reverse Transcriptase Domain of Hepatitis B Virus Polymerase Reduce the Susceptibility to Tenofovir.

Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs.

A Single Amino Acid in the Reverse Transcriptase Domain of Hepatitis B Virus Affects Virus Replication Efficiency.

Impacts of HBV Rth55r Polymerase Substitution on Viral Replication and Rtm204i/v Resistance to Nucleoside/nucleotide Antiviral Drugs.

Prevalence of rt229 polymerase mutations of hepatitis B virus and its influence on the viral replication

Evolution and phenotypic analysis of rtL229 polymerase mutations within the hepatitis B virus genome

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

A pregenomic RNA sequence adjacent to DR1 and complementary to epsilon influences hepatitis B virus replication efficiency.

Rte218g, a Novel Hepatitis B Virus Mutation with Resistance to Adefovir Dipivoxil in Patients with Chronic Hepatitis B

Novel rtM204 Mutations in HBV Polymerase Confer Reduced Susceptibility to Adefovir and Tenofovir

Analysis for phenotypic resistant characteristics of a novel mutation rtN236V in the reverse-transcriptase domain of hepatitis B virus isolated from an adefovir dipivoxil-refractory patient with chronic hepatitis B

Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients.

Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility.

Conserved Residues Adjacent to ß-Barrel and Loop Intersection among Enterovirus VP1 Affect Viral Replication: Potential Target for Anti-Enteroviral Development

Substitutions of Rtl228 And/or L229 Are Involved in the Regulation of Replication and HBsAg Secretion in Hepatitis B Virus, and Do Not Affect Susceptibility to Nucleos(t)ide Analogs

Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.

Prevalence And Significance Of Hepatitis B Reverse Transcriptase Mutants In Different Disease Stages Of Untreated Patients

The Rta181s Mutation of Hepatitis B Virus Primarily Confers Resistance to Adefovir Dipivoxil

Identification of the Critical Regions in Hepatitis B Virus Pres Required for Its Stability